Intracameral antibiotics: Safety, efficacy, and preparation

Packer, 2011, , for the ASCRS Cataract Clinical Committee. Prevention, diagnosis and management of acute postoperative bacterial endophthalmitis., J Cataract Refract Surg, 37, 1699, 10.1016/j.jcrs.2011.06.018 Miller, 2005, Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual outcomes after treatment., Am J Ophthalmol, 139, 983, 10.1016/j.ajo.2005.01.025 2007, Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors., J Cataract Refract Surg, 33, 978, 10.1016/j.jcrs.2007.02.032 Shorstein, 2013, Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department., J Cataract Refract Surg, 39, 8, 10.1016/j.jcrs.2012.07.031 Tan, 2012, Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents., J Cataract Refract Surg, 38, 425, 10.1016/j.jcrs.2011.09.040 Montan, 2002, Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery., J Cataract Refract Surg, 28, 977, 10.1016/S0886-3350(01)01269-X Garcia-Saenz, 2010, Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery; ten-year comparative study., J Cataract Refract Surg, 36, 203, 10.1016/j.jcrs.2009.08.023 Gimbel, 1994, Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss., Eur J Implant Refract Surg, 6, 280, 10.1016/S0955-3681(13)80228-6 Espiritu, 2007, Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients., J Cataract Refract Surg, 33, 63, 10.1016/j.jcrs.2006.09.019 Lane, 2008, Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery., J Cataract Refract Surg, 34, 1451, 10.1016/j.jcrs.2008.05.034 Arbisser, 2008, Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery., J Cataract Refract Surg, 34, 1114, 10.1016/j.jcrs.2008.03.017 Yoeruek, 2008, Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use., J Cataract Refract Surg, 34, 2139, 10.1016/j.jcrs.2008.08.022 Hui, 2011, In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications., Clin Experiment Ophthalmol, 39, 164, 10.1111/j.1442-9071.2010.02402.x Asbell, 2008, Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates., Am J Ophthalmol, 145, 951, 10.1016/j.ajo.2008.01.025 Ferro, 1997, Postoperative contamination after using vancomycin and gentamicin during phacoemulsification., Arch Ophthalmol, 115, 165, 10.1001/archopht.1997.01100150167003 Pflugfelder, 1987, Intravitreal vancomycin: retinal toxicity, clearance, and interaction with gentamicin., Arch Ophthalmol, 105, 831, 10.1001/archopht.1987.01060060117045 Libre, 2003, Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model., J Cataract Refract Surg, 29, 1791, 10.1016/S0886-3350(03)00134-2 1995, Results of the Endophthalmitis Vitrectomy Study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis., Arch Ophthalmol, 113, 1479, 10.1001/archopht.1995.01100120009001 Aaberg, 1998, Nosocomial acute-onset postoperative endophthalmitis survey; a 10- year review of incidence and outcomes., Ophthalmology, 105, 1004, 10.1016/S0161-6420(98)96000-6 Mamalis, 2002, Postoperative endophthalmitis., Curr Opin Ophthalmol, 13, 14, 10.1097/00055735-200202000-00004 Kunimoto, 1999, , the Endophthalmitis Research Group. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis., Am J Ophthalmol, 128, 240, 10.1016/S0002-9394(99)00112-9 Caeiro, 2003, Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity., Expert Rev Anti Infect Ther, 1, 363, 10.1586/14787210.1.3.363 Barman Balfour, 2000, Moxifloxacin; a review of its clinical potential in the management of community-acquired respiratory tract infections., Drugs, 59, 115, 10.2165/00003495-200059010-00010 Asena, 2013, Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5 solution in a rabbit model., Curr Eye Res, 38, 472, 10.3109/02713683.2012.763101 Schlech, 2005, Overview of the potency of moxifloxacin ophthalmic solution 0.5 (VIGAMOX)., Surv Ophthalmol, 50, S7, 10.1016/j.survophthal.2005.05.002 Mather, 2002, Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics., Am J Ophthalmol, 133, 463, 10.1016/S0002-9394(02)01334-X Kowalski, 2005, Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model., Am J Ophthalmol, 140, 497, 10.1016/j.ajo.2005.04.015 Mah, 2004, Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections., Curr Opin Ophthalmol, 15, 316, 10.1097/00055735-200408000-00007 Petty, 1996, Cefuroxime axetil; a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy., Drugs, 52, 125 Geraci, 1977, Vancomycin., Mayo Clin Proc, 52, 631 Schimel, 2013, Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases., Am J Ophthalmol, 156, 50, 10.1016/j.ajo.2013.01.027 OBrien, 2007, Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin., J Cataract Refract Surg, 33, 1790, 10.1016/j.jcrs.2007.06.026 McCulley, 2006, Fourth-generation fluoroquinolone penetration into the aqueous humor in humans., Ophthalmology, 113, 955, 10.1016/j.ophtha.2006.01.061 Solomon, 2005, Penetration of topically applied gatifloxacin 0.3, moxifloxacin 0.5, and ciprofloxacin 0.3 into the aqueous humor., Ophthalmology, 112, 466, 10.1016/j.ophtha.2004.09.029 Ong-Tone, 2007, Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery., J Cataract Refract Surg, 33, 59, 10.1016/j.jcrs.2006.09.015 Katz, 2005, Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor., Cornea, 24, 955, 10.1097/01.ico.0000157423.78275.a2 Kim, 2005, Aqueous penetration and biological activity of moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 solution in cataract surgery patients., Ophthalmology, 112, 1992, 10.1016/j.ophtha.2005.06.017 Lai, 2007, Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy., Am J Ophthalmol, 144, 315, 10.1016/j.ajo.2007.03.036 Lundstrom, 2007, Endophthalmitis after cataract surgery; a nationwide prospective study evaluating incidence in relation to incision type and location., Ophthalmology, 114, 866 Friling, 2013, Six-year incidence of endophthalmitis after cataract surgery: Swedish national study., J Cataract Refract Surg, 39, 15, 10.1016/j.jcrs.2012.10.037 Rodriguez-Caravaca, 2013, Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery., J Cataract Refract Surg, 39, 1399, 10.1016/j.jcrs.2013.03.031 Garat, 2005, Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study., J Cataract Refract Surg, 31, 2230, 10.1016/j.jcrs.2005.08.053 Romero, 2006, Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery., J Cataract Refract Surg, 32, 438, 10.1016/j.jcrs.2005.12.135 Yu-Wai-Man, 2008, Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery., J Cataract Refract Surg, 34, 447, 10.1016/j.jcrs.2007.10.041 Barreau, 2012, Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study., J Cataract Refract Surg, 38, 1370, 10.1016/j.jcrs.2012.03.024 Mendivil, 2000, The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery., Am J Ophthalmol, 131, 293, 10.1016/S0002-9394(00)00651-6 Gordon, 2001, Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes?, Am J Ophthalmol, 131, 371, 10.1016/S0002-9394(00)00955-7 Harper, 2007, In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates., Ophthalmology, 114, 871, 10.1016/j.ophtha.2007.01.007 Freidlin, 2007, Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus., Am J Ophthalmol, 144, 313, 10.1016/j.ajo.2007.03.032 Major, 2010, Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes., Am J Ophthalmol, 149, 278, 10.1016/j.ajo.2009.08.023 Mamalis, 2006, Toxic anterior segment syndrome., J Cataract Refract Surg, 32, 324, 10.1016/j.jcrs.2006.01.065 Delyfer, 2011, Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery., J Cataract Refract Surg, 37, 271, 10.1016/j.jcrs.2010.08.047 Qureshi, 2011, Macular infarction after inadvertent intracameral cefuroxime., J Cataract Refract Surg, 37, 1168, 10.1016/j.jcrs.2011.03.032 Ciftci, 2014, Hemorrhagic retinal infarction due to inadvertent overdose of cefuroxime in cases of complicated cataract surgery: retrospective case series., Am J Ophthalmol, 157, 421, 10.1016/j.ajo.2013.10.018 Lockington, 2010, Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery., J Cataract Refract Surg, 36, 286, 10.1016/j.jcrs.2009.08.034 Gupta, 2005, Macular thickness after cataract surgery with intracameral cefuroxime., J Cataract Refract Surg, 31, 1163, 10.1016/j.jcrs.2004.10.074 Jensen, 2005, A retrospective study of endophthalmitis rates comparing quinolone antibiotics., Am J Ophthalmol, 139, 141, 10.1016/j.ajo.2004.09.020 Moisseiev, 2013, Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery., J Cataract Refract Surg, 39, 1432, 10.1016/j.jcrs.2013.06.008 Villada, 2005, Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery., J Cataract Refract Surg, 31, 620, 10.1016/j.jcrs.2004.06.086 Sharifi, 2009, Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery., Ophthalmology, 116, 1887, 10.1016/j.ophtha.2009.03.014 Chang, 2007, , for the ASCRS Cataract Clinical Committee. Prophylaxis of postoperative endophthalmitis after cataract surgery; results of the 2007 ASCRS member survey., J Cataract Refract Surg, 33, 1801, 10.1016/j.jcrs.2007.07.009